EchoNous, Inc. Announces CE Mark Approval for Its Healthcare AI KOSMOS Platform

The 1st AI-assisted hand-held software to raise diagnostic self-confidence at the bedside

Push Release

updated: Mar twenty, 2020 01:00 EDT

EchoNous is quite delighted to announce that its KOSMOS system has been accredited for CE Marketplaces many thanks to the unbending effort and hard work of its engineering, operations and regulatory teams. The company’s engineering staff has created a professional medical software that, according to doctor feedback, considerably improves supplier self-confidence in bedside diagnostics and scientific final decision-earning with AI-guidance. The CE mark approval was completed on March 16 and is taking place in parallel with EchoNous’ accomplishment of readiness for 1st shipments by March twenty. 

Pursuing several months of scientific evaluations, KOSMOS has been routinely explained by physicians as an “exciting new type of professional medical software.” KOSMOS includes an 8oz ultrasound imaging software with embedded and synchronized ECG and electronic auscultation, and a proprietary pill created to face up to major use in scientific settings although preserving client knowledge.

The KOSMOS system employs a number of levels of used deep finding out aimed at improving upon finding out and self-confidence curves although however serving tremendous users who demand substantial-excellent imaging that can help final decision-earning immediately at the point of care, without the need of demanding a independent device.

At the moment, the KOSMOS AI system can measure systolic coronary heart operate, which has been clinically examined vs. skilled measurements, yielding great benefits in precision and consistency.

In a parallel, EchoNous will soon file for clearance of the 1st-at any time trio of algorithms that will help users to have their graphic excellent graded, their procedure guided, and the coronary heart anatomy labeled by device finding out algorithms. 

The KOSMOS system has been rigorously evaluated in acute care settings, precisely on 300+ clients, and also examined by hundreds of physicians throughout the United States, Canada, Europe and Japan in scientific demonstrations.

EchoNous has validated that KOSMOS is the world’s 1st AI-assisted hand-held software to go the needle into improved diagnostic self-confidence at the bedside, with abilities proven to be equal to cart-based mostly devices – for below US $10,000.

All of these abilities reside in an eight-ounce software related to a tailor made-created pill, the Kosmos Bridge, which runs AI computation capabilities on the Bridge by itself, doing away with the have to have for cloud-connectivity all through use, and preserving client and medical center knowledge although ensuring there are no drops in services all through scanning. The bridge is also created to seamlessly hook up knowledge to the wellbeing procedure IT ecosystem without the need of the have to have for Online connectivity.

Up coming methods for the KOSMOS platform include the release of steady & pulsed wave doppler (Spring 2020).

The KOSMOS system also has a complete suite of scientific deep finding out programs planned for its 12-24-thirty day period street map.

About EchoNous: EchoNous’ vision given that inception has been to produce an unparalleled diagnostic software in the